Source: http://www.google.com/patents/US5919670?ie=ISO-8859-1
Timestamp: 2015-05-25 03:31:25
Document Index: 667060923

Matched Legal Cases: ['Application No. 10037', 'Application No. 134993', 'Application No. 44193', 'Application No. 31093', 'Application No.134993', 'Application No. 273487', 'Application No. 48195', 'Application No. 330275', 'Application No. 893', 'Application No. 12995', 'Application No. 30693', 'Application No.195695', 'Application No. 458', 'Application No. 42988']

Patent US5919670 - Process for producing L-amino acids by fermentation - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsThe present invention provides a process for producing an L-amino acid which comprises culturing in a nutrient medium a microorganism which is capable of producing the L-amino acid and which can not grow in a synthetic medium containing said L-amino acid as the sole nitrogen source in an amount of 5...http://www.google.com/patents/US5919670?utm_source=gb-gplus-sharePatent US5919670 - Process for producing L-amino acids by fermentationAdvanced Patent SearchPublication numberUS5919670 APublication typeGrantApplication numberUS 09/099,036Publication dateJul 6, 1999Filing dateJun 18, 1998Priority dateJun 23, 1997Fee statusPaidAlso published asCA2240963A1, CA2240963C, DE69833469D1, DE69833469T2, EP0887420A2, EP0887420A3, EP0887420B1, US6143552Publication number09099036, 099036, US 5919670 A, US 5919670A, US-A-5919670, US5919670 A, US5919670AInventorsKazuyuki Okamoto, Masato Ikeda, Kuniki KinoOriginal AssigneeKyowa Hakko Kogyo Co., Ltd.Export CitationBiBTeX, EndNote, RefManPatent Citations (17), Referenced by (16), Classifications (21), Legal Events (6) External Links: USPTO, USPTO Assignment, EspacenetProcess for producing L-amino acids by fermentation
US 5919670 AAbstract
The present invention provides a process for producing an L-amino acid which comprises culturing in a nutrient medium a microorganism which is capable of producing the L-amino acid and which can not grow in a synthetic medium containing said L-amino acid as the sole nitrogen source in an amount of 5 mg/ml or below, allowing the L-amino acid to accumulate in the culture, and recovering the L-amino acid from the culture.
1. A process for producing an L-amino acid which comprises culturing in a nutrient medium a microorganism belonging to the species Escherichia coli which is capable of producing said L-amino acid and which cannot grow in a synthetic medium containing said L-amino acid as sole nitrogen source in an amount of 5 mg/ml or below,allowing the L-amino acid to accumulate in the culture, and recovering the L-amino acid from the culture. 2. The process according to claim 1, wherein said microorganism is Escherichia coli H-9244 THN-1.
3. The process according to either of claim 1 or 2, wherein said L-amino acid is L-threonine.
The present invention relates to a process for producing L-amino acids by fermentation. L-amino acids are used as drugs, food products and feed additives.
As the direct fermentation methods for producing L-amino acids directly from sugars, there are known methods in which mutants derived from wild type strains of microorganisms belonging to the genus Corynebacterium, Brevibacterium, Escherichia, Serratia or Arthrobacter are employed. For example, the following are known as L-amino acid-producing mutants: auxotrophic mutants which require amino acids, etc. (Japanese Published Examined Patent Application No. 10037/81), mutants which have resistance to amino acid analogues, vitamins, etc. (Japanese Published Unexamined Patent Application No. 134993/81, Japanese Published Unexamined Patent Application No. 44193/87), mutants which have both auxotrophic mutation and resistance mutation to amino acid analogues (Japanese Published Unexamined Patent Application No. 31093/75, Japanese Published Unexamined Patent Application No.134993/81), mutants which have lowered degradability (Japanese Published Unexamined Patent Application No. 273487/88, Japanese Published Examined Patent Application No. 48195/77) and mutants whose aminoacyl t-RNA-synthesizing enzymes have a decreased substrate affinity (Japanese Published Unexamined Patent Application No. 330275/92). Also known are transformants obtained by transformation with recombinant DNAs containing genes related to the biosynthesis of amino acids (Japanese Published Unexamined Patent Application No. 893/83, Japanese Published Unexamined Patent Application No. 12995/85, Japanese Published Unexamined Patent Application No. 30693/85, Japanese Published Unexamined Patent Application No.195695/86, Japanese Published Unexamined Patent Application No. 458/90, Japanese Published Unexamined Patent Application No. 42988/90).
Because of a growing demand for L-amino acids for use as drugs, food products and feed additives in recent years, there is an increasing need for the improvement of processes for producing L-amino acids. An object of the present invention is to provide an industrially efficient process for producing L-amino acids which are useful as drugs, food products and feed additives.
The present invention provides a microorganism which is capable of producing an L-amino acid and which can not grow in a synthetic medium containing said L-amino acid as the sole nitrogen source at a concentration of 5 mg/ml or below; and a process for producing an L-amino acid which comprises culturing said microorganism in a nutrient medium, allowing the L-amino acid to accumulate in the culture, and recovering the L-amino acid from the culture.
Examples of the L-amino acids produced in the present invention include L-asparagine, L-aspartic acid, L-alanine, L-arginine, L-isoleucine, L-glycine, L-glutamine, L-glutamic acid, L-cysteine, L-serine, L-tyrosine, L-tryptophan, L-threonine, L-valine, L-histidine, L-phenylalanine, L-proline, L-methionine, L-lysine, L-leucine, etc. A preferabe example is L-threonine.
Generally, microorganisms have enzymes having the activity to release ammonia from L-amino acids, such as L-amino acid dehydrogenase, L-amino acid oxidase and L-amino acid dehydratase, and enzymes having the activity to transfer ammonia from L-amino acids to keto acids, such as L-amino acid transaminase, and thus can grow in a synthetic medium containing an L-amino acid as the sole nitrogen source at such a low concentration as 5 mg/ml or below.
In accordance with the present invention, L-amino acid productivity can be improved by the use of a microorganism which is capable of producing the L-amino acid and which can not grow in a synthetic medium containing said L-amino acid as the sole nitrogen source in an amount of 5 mg/ml or below, whereby an industrially efficient process for producing L-amino acids is provided.
In the present invention, any microorganism may be used so long as it is capable of producing an L-amino acid and can not grow in a synthetic medium containing said L-amino acid as the sole nitrogen source at a concentration of 5 mg/ml or below. For example, microorganisms belonging to the genus Corynebacterium, Brevibacterium, Escherichia, Serratia or Arthrobacter which are capable of producing an L-amino acid and can not grow in a synthetic medium containing said L-amino acid as the sole nitrogen source at a concentration of 5 mg/ml or below may be used. Examples of the suitable species include Corynebacterium glutamicum, Brevibacterium ammmoniagenes, Escherichia coli, Serratia marcescens and Arthrobacter paraffineus. A typical example of a suitable strain is Escherichia coli H-9244 THN-1 strain.
The microorganisms of the present invention can be obtained by subjecting microorganisms capable of producing an L-amino acid to a conventional mutation treatment, or cell fusion, transduction or other recombinant DNA techniques, and then by selecting microorganisms which can not grow in a synthetic medium containing the L-amino acid as the sole nitrogen source in an amount of 5 mg/ml or below.
The microorganisms of the present invention may additionally have properties to improve L-amino acid productivity, for example, auxotrophic mutation, drug resistance and drug sensitivity.
As the synthetic medium, a minimal medium can be employed when the microorganism of the present invention is aprototroph. When the microorganism of the present invention is an auxotroph, a medium prepared by adding the required nutrient to the minimal medium can be employed.
The production of L-amino acids by using the microorganisms of the present invention can be carried out by an ordinary method for culturing bacteria.
As the medium used for the production of L-amino acids, any of synthetic media and natural media can be employed as long as it appropriately contains carbon sources, nitrogen sources, inorganic substances and trace amounts of nutrients which the strain used requires.
Examples of the carbon sources include carbohydrates such as glucose, fructose, lactose, molasses, cellulose hydrolyzate, crude sugar hydrolyzate and starch hydrolyzate, organic acids such as pyruvic acid, acetic acid, fumaric acid, malic acid and lactic acid, and alcohols such as glycerin and ethanol.
Examples of the nitrogen sources include ammonia, various inorganic salts (such as ammonium chloride, ammonium sulfate, ammonium acetate and ammonium phosphate), ammonium salts of organic acids, amines, peptone, meat extract, corn steep liquor, casein hydrolyzate, soybean cake hydrolyzate, various fermented cells and digested matters thereof.
Examples of the inorganic substances include potassium dihydrogenphosphate, dipotassium hydrogenphosphate, magnesium phosphate, magnesium sulfate, magnesium chloride, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate, calcium chloride and calcium carbonate.
Culturing is carried out under aerobic conditions, for example, by shaking culture or spinner culture under aeration. The culturing temperature is in the range of 20 to 40� C., preferably 28 to 37� C. The pH of the medium is in the range of pH 5 to 9, preferably around neutrality. The pH adjustment is carried out by using calcium carbonate, an organic or inorganic acid, an alkali solution, ammonia, a pH buffer, etc. Usually, an L-amino acid is formed and accumulated in the culture by 1 to 7 days of culturing.
After the culturing is completed, precipitates such as cells are removed from the culture, and the L-amino acid can be recovered from the culture by means of ion exchange chromatography, concentration, salting-out, etc. in combination.
Acquisition of microorganisms which can not grow in a synthetic medium containing an L-amino acid as the sole nitrogen source in an amount of 5 mg/ml or below
Escherichia coli H-7700, which is a non-diaminopimelic-acid-requiring strain derived from Escherichia coli H-4581 (FERMBP-1411) having requirement for diaminopimelic acid, was subjected to mutation treatment using N-methyl-N'-nitro-N-nitrosoguanidine according to a conventional method (0.2 mg/ml, at 30� C. for 30 minutes), and then spread on a synthetic agar plate medium 0.5% glucose, 0.3% potassium dihydrogenphosphate, 0.6% disodium hydrogenphosphate, 0.01% magnesium sulfate, 0.2% ammonium chloride, 20 mg/l calcium chloride, 20 mg/l required nutrient (DL-methionine) and 2% agar, pH 7.2!.
Culturing was carried out at 30� C. for 2 to 6 days, and the colonies growing on the plate (about 104) were picked up and replicated on synthetic agar media containing L-threonine as the sole nitrogen source in place of ammonium chloride in the above synthetic medium at a concentration of 1 mg/ml and 10 mg/ml, respectively.
Culturing was carried out at 30� C. for 2 days, and about 30 strains were obtained which could not grow on the medium containing 1 mg/ml L-threonine but could grow on the medium containing 10 mg/ml L-threonine.
L-threonine production test was carried out on the obtained strains in the same manner as in Example 3.
A strain having markedly improved L-threonine productivity was named Escherichia coli H-9244 THN-1.
The strain H-9244 THN-1 was deposited with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology on Jun. 19, 1997 as FERM BP-5985 under the Budapest Treaty.
Comparative test on the growth of the strains on synthetic agar plate media containing L-threonine as the sole nitrogen source
The degree of growth of the mutant H-9244 THN-1 obtained in Example 1 was compared with that of the parent strain H-7700 using synthetic agar plate media containing L-threonine as the sole nitrogen source.
Each of the strains which had been cultured in a natural medium for 24 hours was suspended in physiological saline, and the resulting suspension was spread on synthetic agar plate media containing L-threonine as the nitrogen source at varied concentrations (1 to 15 mg/ml) and 20 mg/l DL-methionine which is the required amino acid at a cell density of 1 to 10 cells/cm2. Culturing was carried out at 33� C. for 4 days.
The sizes of the colonies which appeared on the media by the culturing are shown in Table 1.
H-7700 strain could grow on any of the synthetic agar media containing L-threonine as the sole nitrogen source, whereas H-9244 THN-1 strain could not grow at all on the synthetic agar media containing L-threonine as the sole nitrogen source at concentrations of 5 mg/ml or below.
TABLE 1______________________________________    Nitrogen source (L-threonine)Strain     0     1      3   5    7   10   15  (mg/ml)______________________________________H-7700     -     �   +   +    +   +    +H-9244 THN-1      -     -      -   -    �                                � +______________________________________ +: Good growth (colony size: 1-3 mm) �: Capable of growth (colony size: &#8806;0.5 mm) -: No growth (No colony formation observed)
Production of L-threonine using the mutant H-9244 THN-1 obtained in Example 1 and its parent strain H-7700 was carried out in the following manner.
Each of H-9244 THN-1 strain and H-7700 strain was inoculated into 6 ml of a seed medium (2% glucose, 1% peptone, 1% yeast extract, 0.25% NaCl, 130 mg/l DL-methionine and 1% calcium carbonate, pH 7.0) in a large test tube, followed by shaking culture at 30� C. for 16 hours.
Then, 0.1 ml of the obtained seed culture was inoculated into 5 ml of a production medium (6% glucose, 0.2% corn steep liqour, 1.6% ammonium sulfate, 0.1% potassium dihydrogenphosphate, 100 mg/l DL-methionine, 4% magnesium phosphate and 1% calcium carbonate, pH 7.0) in a large test tube, followed by shaking culture at 30� C. for 48 hours.
After the culturing was completed, the amount of L-threonine accumulated in the culture was determined by high performance liquid chromatography.
The L-threonine productivity of H-9244 THN-1 strain was significantly improved compared with that of the parent strain H-7700.
TABLE 2______________________________________Strain        L-threonine (g/l)______________________________________H-7700        1.5H-9244 THN-1  5.0______________________________________
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS4463094 *Mar 17, 1981Jul 31, 1984Tanabe Seiyaku Co., Ltd.Fermentation production of L-threonineUS4996147 *Jul 28, 1988Feb 26, 1991Kyowa Hakko Kogyo Co., Ltd.Process for producing L-threonine by fermentationUS5017483 *Feb 12, 1987May 21, 1991Kyowa Hakko Kogyo Co., Ltd.Process for producing L-threonineUS5264353 *Feb 7, 1991Nov 23, 1993Toray Industries, Inc.Process for producing L-threonine by fermentationJPH02458A * Title not availableJPH0242988A * Title not availableJPH04330275A * Title not availableJPS58893A * Title not availableJPS5031093A * Title not availableJPS5248195A * Title not availableJPS5610037A * Title not availableJPS6012995A * Title not availableJPS6030693A * Title not availableJPS6244193A * Title not availableJPS56134993A * Title not availableJPS61195695A * Title not availableJPS63273487A * Title not available* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS6451564Jun 30, 2000Sep 17, 2002Massachusetts Institute Of TechnologyMethods for producing L-isoleucineUS6927046Nov 28, 2000Aug 9, 2005Archer-Daniels-Midland CompanyIncreased lysine production by gene amplification using coryneform bacteriaUS6987017Aug 20, 2002Jan 17, 2006Massachusetts Institute Of TechnologyMethods for producing L-isoleucineUS7045320Dec 20, 2002May 16, 2006Ajinomoto Co., Inc.Methods for producing L-amino acidsUS7244608Aug 23, 2002Jul 17, 2007Cheil Jedang CorporationMicroorganism producing 5′-inosinic acid and process for producing 5′-inosinic acid using the sameUS7741460Feb 4, 2004Jun 22, 2010Archer-Daniels-Midland CompanyPolynucleotides encoding a truncated ORF2 from CorynebacteriumUS8052968Oct 16, 2007Nov 8, 2011Genelux CorporationModified vaccinia virus strains for use in diagnostic and therapeutic methodsUS8066984Apr 4, 2008Nov 29, 2011Genelux CorporationModified vaccinia virus strains for use in diagnostic and therapeutic methodsUS8067210May 3, 2010Nov 29, 2011Hanke Paul DMethod of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from corynebacteriumUS8852927Feb 23, 2010Oct 7, 2014Genelux CorporationMicroorganisms for imaging and/or treatment of tumorsUS8865153May 10, 2012Oct 21, 2014Genelux CorporationMicroorganisms for imaging and/or treatment of tumorsUS9005602Aug 2, 2011Apr 14, 2015Genelux CorporationModified vaccinia virus strains for use in diagnostic and therapeutic methodsEP2415783A1Oct 16, 2007Feb 8, 2012Genelux CorporationModified vaccinia virus strains for use in a diagnostic and therapeutic methodEP2426142A2Oct 16, 2007Mar 7, 2012Genelux CorporationModified vaccinia virus strains for use in a diagnostic and therapeutic methodWO2013138522A2Mar 13, 2013Sep 19, 2013Genelux CorporationMethods for assessing effectiveness and monitoring oncolytic virus treatmentWO2013158265A1Mar 13, 2013Oct 24, 2013Genelux CorporationImaging methods for oncolytic virus therapyClassifications U.S. Classification435/106, 435/110, 435/113, 435/115, 435/252.33, 435/108, 435/252.8, 435/107, 435/109, 435/114, 435/116, 435/849International ClassificationC12P13/04, C12P13/08, C12R1/19, C12N1/20Cooperative ClassificationY10S435/849, C12P13/08, C12P13/04European ClassificationC12P13/08, C12P13/04Legal EventsDateCodeEventDescriptionDec 8, 2010FPAYFee paymentYear of fee payment: 12Mar 17, 2009ASAssignmentOwner name: KYOWA HAKKO BIO CO., LTD., JAPANFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KYOWA HAKKO KOGYO CO., LTD.;REEL/FRAME:022399/0602Effective date: 20081001Dec 18, 2006FPAYFee paymentYear of fee payment: 8Dec 13, 2002FPAYFee paymentYear of fee payment: 4Mar 7, 2000CCCertificate of correctionJun 18, 1998ASAssignmentOwner name: KYOWA HAKKO KOGYO CO., LTD., JAPANFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OKAMOTO, KAZUYUKI;KINO, KUNIKI;IKEDA, MASATO;REEL/FRAME:009265/0926Effective date: 19980608RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services